Eric Schadt, a serial entrepreneur and expert in computational biology, is leaving his post as Chief Scientist at Pathos AI ...

Johnson & Johnson has secured another approval for its multiple myeloma drug Tecvayli (teclistamab), with the European ...

DMD affects approximately 15,000 individuals in the United States and primarily impacts boys. Over time, deterioration of the ...

Kinvard Bio is one of the few companies seriously trying to change that. It started as a scientific spinout from the Andrew ...

More than 20,000 biotechnology leaders gathered in San Diego for the 2026 BIO International Convention under the theme, ...

England is one of a handful of countries globally to have already exceeded the WHO benchmark of treating 80% of all known ...

Sanofi is laying off 229 former Blueprint Medicines employees in Cambridge, MA and closing two legacy Blueprint facilities.

US President Donald Trump has nominated White House health policy aide Heidi Overton to take up the mantle of commissioner ...

But Sohonos has not lived up to its sales potential, despite being the only drug on the market, perhaps owing to relatively ...

Actio is the third acquisition for Jazz in the last few years, coming after it bought Chimerix for $935 million last year and ...

The Advanced Research Projects Agency for Health (ARPA-H) has awarded Siemens Healthineers up to $31.1 million over five years to accelerate the development of autonomous, remote, endovascular ...

Join Amiculum for an exclusive live webinar and audience Q&A to gain practical insights from global payer research and ...